RYTHM Reports Reduced Q4 Loss Year-Over-Year Due to Increased Licensing Revenue

RYTHM, Inc. Outperforms Market Following Q4 2025 Results

RYTHM, Inc. (RYM) saw its shares rise by 5.3% after announcing its financial results for the quarter ending December 31, 2025. This performance surpassed the S&P 500 Index, which fell 2.1% during the same period. Despite a 2.1% dip in RYTHM’s stock over the past month, it still fared better than the S&P 500’s 3.1% decrease.

Quarterly Financial Highlights

In the fourth quarter of 2025, RYTHM reported a net loss of $6.62 per share, a notable improvement from the $15.32 per share loss in the same quarter last year.

Revenue from ongoing operations reached $10.7 million, a substantial jump from the previous year’s $0.01 million. Gross profit climbed to $8 million, reversing last year’s gross loss of $0.07 million and indicating stronger profit margins.

Despite robust revenue growth, the company recorded a net loss of $13.6 million, which was an improvement compared to the $24.4 million loss in Q4 2024.

RYTHM, Inc. Price, Consensus and EPS Surprise

View Price, Consensus, and EPS Surprise Chart | See RYTHM, Inc. Quote

Key Business Metrics

RYTHM’s gross margin surged to approximately 75% in Q4, up from 34% in the previous quarter.

Operating results remained challenged, with an operating loss from continuing operations totaling $12.9 million. This was largely due to an $8.5 million non-cash impairment charge.

At year-end, RYTHM held $32.2 million in cash. The company reported about 2.1 million shares outstanding, along with warrants convertible into 10.9 million shares and convertible notes exchangeable for roughly 3 million shares, not including interest.

Leadership Insights

Ben Kovler, Chairman and Interim CEO, described 2025 as a pivotal year for RYTHM. Management emphasized the company’s rebranding and strategic shift toward expanding its footprint in the hemp-derived THC sector. The brand portfolio—including RYTHM, Dogwalkers, and Señorita—was highlighted as central to the company’s growth plans.

Kovler pointed out that licensing revenue was a major contributor to the quarter, with around $7 million recognized, including two months of income from a newly acquired brand that began generating licensing revenue on November 1.

Management also noted increasing consumer interest in THC products, despite regulatory hurdles. The company continues to prioritize expanding access to THC beverages and related products in retail and entertainment venues.

Quarter Drivers and Strategic Moves

Several initiatives fueled the quarter’s results and overall momentum. In 2025, RYTHM acquired intellectual property for brands such as RYTHM, Dogwalkers, incredibles, and Beboe. The company earned $7.8 million in licensing fees by partnering with Green Thumb Industries.

Distribution of hemp-derived THC beverages expanded, with products now available in over 6,000 retail locations across 18 states. A significant milestone was the placement of Señorita THC Margaritas in more than 800 Circle K stores, marking one of the largest convenience-store launches for hemp-derived THC beverages in the U.S.

RYTHM also introduced Señorita THC Margaritas and RYTHM Beverages at Chicago’s United Center through a multi-year partnership, making it the first major U.S. arena to offer THC beverages.

2025 Full-Year Update

For the year, RYTHM’s revenue reached $17.3 million, up from $0.01 million in 2024. Gross profit improved to $10.2 million, compared to a gross loss of $0.07 million the previous year. Net loss narrowed to $33.3 million from $41.7 million, and net loss per share decreased to $16.68 from $40.92.

Additional Developments

RYTHM continued to execute strategic actions to strengthen its brand portfolio and market position. Acquiring multiple cannabis-related brand intellectual properties in 2025 expanded the company’s portfolio and supported its licensing strategy. Management believes that owning established brands will provide lasting strategic benefits as the hemp and cannabis markets evolve.

The company also acknowledged ongoing regulatory uncertainty regarding hemp-derived THC products, including potential impacts from federal policy changes. Despite these challenges, management remains committed to building consumer-focused brands and increasing product availability in retail and entertainment venues.

Stocks with High Growth Potential

Zacks experts have selected five stocks expected to potentially double in value over the next year. Previous picks have achieved gains of +112%, +171%, +209%, and +232%.

Many of these stocks are not widely followed on Wall Street, offering investors a unique opportunity to invest early.

Discover 5 Potential High-Growth Stocks >>

For the latest stock recommendations from Zacks Investment Research, you can download the "7 Best Stocks for the Next 30 Days." Get your free report here.

RYTHM, Inc. (RYM): Complimentary Stock Analysis Report

Original article published by Zacks Investment Research

Zacks Investment Research